Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions
出版年份 2015 全文链接
标题
Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions
作者
关键词
-
出版物
Frontiers in Immunology
Volume 6, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2015-02-04
DOI
10.3389/fimmu.2015.00039
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms
- (2014) Vaheh Oganesyan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibodies to watch in 2014
- (2014) Janice M Reichert mAbs
- Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody
- (2014) Céline Monnet et al. mAbs
- Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy
- (2014) A. Hiatt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies
- (2014) Caitlin Gillis et al. Frontiers in Immunology
- A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults
- (2013) Gabriel J. Robbie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
- (2013) Timo Rath et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity
- (2013) Rintaro Moroi et al. IMMUNOGENETICS
- Antibodies to watch in 2014
- (2013) Janice M Reichert mAbs
- Immune suppression in cynomolgus monkeys by XPro9523
- (2013) Matthew J. Bernett et al. mAbs
- Correlations between pharmacokinetics of IgG antibodies in primates vs. FcRn-transgenic mice reveal a rodent model with predictive capabilities
- (2013) Susan H. Tam et al. mAbs
- Humanized FcRn mouse models for evaluating pharmacokinetics of human IgG antibodies
- (2013) Gabriele Proetzel et al. METHODS
- Engineered Monoclonal Antibody with Novel Antigen-Sweeping Activity In Vivo
- (2013) Tomoyuki Igawa et al. PLoS One
- Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
- (2013) E. M. Pridgen et al. Science Translational Medicine
- Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab
- (2012) A Ruyssen-Witrand et al. ANNALS OF THE RHEUMATIC DISEASES
- Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia
- (2012) Nichola Cooper et al. BRITISH JOURNAL OF HAEMATOLOGY
- Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
- (2012) D. Loo et al. CLINICAL CANCER RESEARCH
- The interactions of therapeutic antibodies with Fc receptors
- (2012) Marcello Albanesi et al. IMMUNOLOGY LETTERS
- Marketing approval of mogamulizumab
- (2012) Alain Beck et al. mAbs
- Autonomous phagosomal degradation and antigen presentation in dendritic cells
- (2012) E. Hoffmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Whole-Molecule Antibody Engineering: Generation of a High-Affinity Anti-IL-6 Antibody with Extended Pharmacokinetics
- (2011) Donna K. Finch et al. JOURNAL OF MOLECULAR BIOLOGY
- Neonatal Fc receptor and IgG-based therapeutics
- (2011) Timothy T. Kuo et al. mAbs
- Efficient mucosal vaccination mediated by the neonatal Fc receptor
- (2011) Lilin Ye et al. NATURE BIOTECHNOLOGY
- Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells
- (2011) K. Baker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
- (2011) L. Zeitlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Therapeutic Anti-VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life
- (2010) Y. A. Yeung et al. CANCER RESEARCH
- Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor- Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys
- (2010) R. Deng et al. DRUG METABOLISM AND DISPOSITION
- Neonatal Fc Receptor: From Immunity to Therapeutics
- (2010) Timothy T. Kuo et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Identification of IgG1 variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: Comparison of soluble receptor-based and cell-based binding assays
- (2010) Yanmei Lu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies
- (2010) M Le Garff-Tavernier et al. LEUKEMIA
- Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions
- (2010) Gregory L. Moore et al. mAbs
- Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
- (2010) Tomoyuki Igawa et al. NATURE BIOTECHNOLOGY
- Enhanced antibody half-life improves in vivo activity
- (2010) Jonathan Zalevsky et al. NATURE BIOTECHNOLOGY
- Optimization of Fc-mediated effector functions of monoclonal antibodies
- (2009) William R Strohl CURRENT OPINION IN BIOTECHNOLOGY
- Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding
- (2009) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
- (2009) Frédéric Bibeau et al. JOURNAL OF CLINICAL ONCOLOGY
- Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates
- (2009) Y. A. Yeung et al. JOURNAL OF IMMUNOLOGY
- Structural characterization of a human Fc fragment engineered for extended serum half-life
- (2009) Vaheh Oganesyan et al. MOLECULAR IMMUNOLOGY
- A human anti-D monoclonal antibody selected for enhanced FcγRIII engagement clears RhD+autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies
- (2008) Roland Beliard et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16
- (2008) Christophe de Romeuf et al. BRITISH JOURNAL OF HAEMATOLOGY
- Potent In vitro and In vivo Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia
- (2008) H. M. Horton et al. CANCER RESEARCH
- When binding is enough: nonactivating antibody formats
- (2008) Aran F Labrijn et al. CURRENT OPINION IN IMMUNOLOGY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimization of antibody binding to Fc RIIa enhances macrophage phagocytosis of tumor cells
- (2008) J. O. Richards et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies
- (2008) Seung Y. Chu et al. MOLECULAR IMMUNOLOGY
- Dependence of antibody-mediated presentation of antigen on FcRn
- (2008) S.-W. Qiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started